
Claritev Corporation (($CTEV)) has held its Q3 earnings call. Read on for the main highlights of the call. Claritev’s latest earnings call carried a strongly positive tone, with revenue, adjusted
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CTEV | Claritev | 18.28 | -28.84 | -61.21% |
| Name | Price | % Change | |
|---|---|---|---|
| $18.28 | -61.21% |

Claritev Corporation (($CTEV)) has held its Q3 earnings call. Read on for the main highlights of the call. Claritev’s latest earnings call carried a strongly positive tone, with revenue, adjusted

Canaccord analyst Richard Close raised the firm’s price target on Claritev (CTEV) to $47 from $43 and keeps a Buy rating on the shares. The firm said an across-the-board 3Q

Consensus is for FY26 revenue $ 1.01B. Raises FY26 Adjusted EBITDA view to $625M-$630M from $610M-$620M. Raises FY26 Free Cash Flow view to $10M-$20M from $5M-$15M. Published first on TheFly

Reports Q3 revenue $268.3M, consensus $ 256.13M. Reports Q4 Adjusted EBITDA $162.0M, an increase of 4.4%, compared to Adjusted EBITDA of $155.1M last year. “This quarter captured what we mean

Claritev Corporation (CTEV) is scheduled to report 3rd quarter earnings on 11/09/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Claritev Corporation to post earnings of -$3.63

Claritev ( ($CTEV) ) just unveiled an announcement. On October 15, 2026, Claritev expanded its Board of Directors from eleven to twelve members and appointed Jennifer (Jenni) Main as a

Claritev (CTEV) Corporation has been selected by General Dynamics Information Technology to support the World Trade Center Health Program. The WTC Health Program is a limited federal health care program

The latest announcement is out from Claritev ( ($CTEV) ). On September 14, 2026, Claritev Corporation appointed AI expert Ben Letham to its Board of Directors as a Class I

Claritev (CTEV) announced that its Board of Directors has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham currently serves as

Barclays analyst Glen Santangelo raised the firm’s price target on Claritev (CTEV) to $40 from $28 and keeps an Overweight rating on the shares. Published first on TheFly – the
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $324.93M | $-3.19 | $270.00M | 0.03 | -1.16 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.